Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

References

• Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135:90–896. doi:10.1016/j.jaci.2014.08.042
   Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Dalal AA, et al. Utilization and costs of severe uncontrolled asthma in a managed-care setting. J Allergy Clin Immunol Pract. 2016;4:120–129. doi:10.1016/j.jaip.2015.08.00326439182
   PubMed Web of Science ®Google Scholar
• Bourdin A, Fabry-Vendrand C, Ostinelli J, et al. The burden of severe asthma in France: a case-control study using a medical claims database. J Allergy Clin Immunol Pract. 2019;7:1477–1487. doi:10.1016/j.jaip.2018.12.02930685573
   PubMed Web of Science ®Google Scholar
• Vianello A, Caminati M, Andretta M, et al. Prevalence of severe asthma according to the drug regulatory agency perspective: an Italian experience. World Allergy Organ J. 2019;12(4):100032. doi:10.1016/j.waojou.2019.10003231193146
   PubMed Web of Science ®Google Scholar
• O’Neill S, Sweeney J, Patterson CC, et al. The cost of treating severe refractory asthma in the UK: an economic analysis from the British thoracic society difficult asthma registry. Thorax. 2015;70(4):376–378. doi:10.1136/thoraxjnl-2013-20411424917087
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Ulrik C, Skjold T, et al. Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults. Eur Clin Respir J. 2018;5(1):1440868.29535852
   PubMed Web of Science ®Google Scholar
• Albers FC, Müllerová H, Gunsoy NB, et al. Biologic treatment eligibility for real-world patients with severe asthma: the IDEAL study. J Asthma. 2018;55(2):152–160. doi:10.1080/02770903.2017.132261128622052
   PubMed Web of Science ®Google Scholar
• Ilmarinen P, Tuomisto LE, Niemelä O, Kankaanranta H. Prevalence of patients eligible for anti-il-5 treatment in a cohort of adult-onset asthma. J Allergy Clin Immunol Pract. 2019;7(1):165–174.e4. doi:10.1016/j.jaip.2018.05.03229894793
   PubMed Web of Science ®Google Scholar
• Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;108(12):1723–1732. doi:10.1016/j.rmed.2014.10.00725456708
   PubMed Web of Science ®Google Scholar
• Global initiative on asthma. Available from: http://ginasthma.org/. Accessed 7 2020.
   Google Scholar
• Global initiative for chronic obstructive lung diseases. Available from: https://goldcopd.org/. Accessed 7 2020.
   Google Scholar
• Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(22):672–688. doi:10.1183/09031936.03.0004070314582923
   PubMed Web of Science ®Google Scholar
• Gosens R, Groos N. The mode of action of anticholinergics in asthma. Eur Resp J. 2018;52:1701247. doi:10.1183/13993003.01247-2017
   PubMed Web of Science ®Google Scholar
• Canning BJ, Reflex regulation of airway smooth muscle tone. J Appl Physiol. 2006;101:971–985. doi:10.1152/japplphysiol.00313.200616728519
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The pharmacological properties of tiotropium. Chest. 2000;117(2_suppl):63S–66S. doi:10.1378/chest.117.2_suppl.63S10673478
   PubMed Web of Science ®Google Scholar
• Coe CI, Barnes PJ. Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest. 1986;90:485–488. doi:10.1378/chest.90.4.4853530643
   PubMed Web of Science ®Google Scholar
• Morrison JF, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. Br Med J. 1988;296(6634):1427–1429. doi:10.1136/bmj.296.6634.14273132275
   PubMed Web of Science ®Google Scholar
• O’Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Resp Crit Care Med. 1996;154(4 Pt 1):876–880. doi:10.1164/ajrccm.154.4.88875788887578
   PubMed Web of Science ®Google Scholar
• Terzano C, Petroianni A, Ricci A, D’Antoni L, Allegra L. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness. Eur Rev Med Pharmacol Sci. 2004;8(6):259–264.15745385
   PubMedGoogle Scholar
• Hamelmann E, Bateman ED, Vogelberg C, et al. Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial. J Allergy Clin Immunol. 2016;138(2):441–450. doi:10.1016/j.jaci.2016.01.01126960245
   PubMed Web of Science ®Google Scholar
• Kew KM, Evans DJ, Allison DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma. Cochrane Database Syst Rev. 2015;6:CD011438.
   PubMed Web of Science ®Google Scholar
• Abadoglu O, Berk S. Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data. Clin Respir J. 2016;10(4):421–427. doi:10.1111/crj.1223025335652
   PubMed Web of Science ®Google Scholar
• Cook AL, Kinane TB, Nelson BA. Tiotropium use in pediatric patients with asthma or chronic cough: a case series. Clin Pediatr. 2014;53(14):1393–1395. doi:10.1177/0009922814525836
   Web of Science ®Google Scholar
• Price D, Kaplan A, Jones R, et al. Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide. J Asthma Allergy. 2015;14:1–13.
   Google Scholar
• Senna G, Guerriero M, Paggiaro PL, et al. SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy. 2017;15(1):9. doi:10.1186/s12948-017-0065-428400707
   PubMedGoogle Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.0020201324337046
   PubMed Web of Science ®Google Scholar
• 3rd edition recommendation on registries for evaluating patient outcomes – effective health care program of the agency for healthcare research and quality. Available from: https://effectivehealthcare.ahrq.gov/topics/registries-guide-3rd-edition/research/. Accessed 1013, 2020.
   Google Scholar
• Commission directive 91/507/EEC of 19 July 1991 modifying the annex to council directive 75/318/eec on the approximation of the laws of member states relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. Available from: https://op.europa.eu/en/publication-detail/-/publication/98ea0b12-c69c-4608-a406-001e48ed29a5/language-en. Accessed 1013, 2020.
   Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.00814713908
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x10573240
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the asthma quality of life questionnaire. Chest. 1999;115(5):1265–1270. doi:10.1378/chest.115.5.126510334138
   PubMed Web of Science ®Google Scholar
• Wang E, Wechsler ME, Tran TN, et al. Characterization of severe asthma worldwide: data from the international severe asthma registry. Chest. 2020;157(4):790–804. doi:10.1016/j.chest.2019.10.05331785254
   PubMed Web of Science ®Google Scholar
• Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S. Characterizing real-world use of tiotropium in asthma in the USA. J Asthma Allergy. 2019;12:309–321. doi:10.2147/JAA.S21693231632091
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367:1198–1207. doi:10.1056/NEJMoa120860622938706
   PubMed Web of Science ®Google Scholar
• Khurana S, Paggiaro P, Buhl R, et al. Tiotropium reduces airflow obstruction in asthma patients, independent of body mass index. J Allergy Clin Immunol Pract. 2019;7(7):2425–2428. doi:10.1016/j.jaip.2019.03.00730898691
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN, Vincken W, Virchow JC, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107(12):1817–1821. doi:10.1016/j.rmed.2013.09.01324120398
   PubMed Web of Science ®Google Scholar
• Heffler E, Paoletti G, Giorgis V, et al. Real-life studies of biologics used in asthma patients: key differences and similarities to trials. Expert Rev Clin Immunol. 2019;15(9):951–958. doi:10.1080/1744666X.2019.165375831389304
   PubMed Web of Science ®Google Scholar